#3-19E. Clearing the Air: Prenatal Paracetamol and Child Neurodevelopment (Lancet Obstet Gynaecol Womens Health, 2026)

Does prescribing paracetamol during pregnancy truly heighten the risk of neurodevelopmental disorders in offspring? This episode explores a pivotal 2026 systematic review and meta-analysis focusing on the debated link between prenatal acetaminophen exposure and conditions like autism spectrum disorder (ASD), ADHD, and intellectual disability. Analyzing data from 43 cohort studies, the researchers prioritized sibling-comparison designs to rigorously control for shared genetic and environmental confounders that often bias observational data. The study’s most critical discovery is that prenatal paracetamol exposure is not associated with an increased risk of ASD, ADHD, or intellectual disability when familial factors are accounted for, suggesting that previously reported associations were likely artifacts of residual confounding rather than causal drug effects. However, in critically appraising this evidence, physicians should note the heterogeneity in exposure measurement and diagnostic criteria across the included historical cohorts. For the practicing clinician, these findings are vital; they reinforce current safety guidelines that paracetamol remains an appropriate first-line therapy, and highlight that avoiding it based on inconclusive evidence may inadvertently expose pregnant patients to the proven dangers of untreated maternal fever and pain.

Citation: D’Antonio F, et al. Prenatal paracetamol exposure and child neurodevelopment: a systematic review and meta-analysis. Lancet Obstet Gynaecol Womens Health. 2026. DOI: 10.1016/S3050-5038(25)00211-0

Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.